title: Laparoscopic splenectomy. The emerging standard.
abstract: BACKGROUND
  The purpose of this study was to evaluate the outcome of patients undergoing laparoscopic splenectomy (LS) at the University of California, San Francisco.
  
  
  METHODS
  The medical records of the initial 52 unselected patients undergoing LS were reviewed and compared to 28 concurrently treated open splenectomy patients (OS).
  
  
  RESULTS
  Patients did not differ with regard to age, gender, body, or splenic weights. The operative time was longer in the LS patients (mean 196 vs 156 min), but the length of stay and duration of ileus were shorter in the LS group. For adult patients admitted exclusively for splenectomy, operative times did not differ between LS and OS and total hospital cost was less in the LS group (mean $8, 939 vs $14,022). Six patients required conversion to OS, four occurring in the first 11 patients treated (overall conversion rate of 11%). Three patients died from complications related to their underlying disease. Two other major complications occurred. Complication rates and transfusion requirements did not differ between OS and LS patients.
  
  
  CONCLUSIONS
  Laparoscopic splenectomy is a safe and effective alternative to open splenectomy for treatment of hematologic diseases in patients of all ages.
authors.affiliation: Department of Surgery, University of California, San Francisco, 533 Parnassus Avenue, U-122, San Francisco, CA 94143-0788, USA.
authors.forename: R E
authors.initials: RE
authors.lastname: Glasgow
authors.forename: L F
authors.initials: LF
authors.lastname: Yee
authors.forename: S J
authors.initials: SJ
authors.lastname: Mulvihill
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016009:Chi-Square Distribution; D002648:Child; D002675:Child, Preschool; D005069:Evaluation Studies as Topic; D005260:Female; D006402:Hematologic Diseases / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods*; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013156:Splenectomy / Q000009:adverse effects / Q000379:methods*